NCT00753844 2012-04-06
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer
Kinki University
Phase 1 Completed
Clinical Trials
3 trialsNCT00681421 2009-11-19
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer
Tokyo University
Phase 1/2 Completed
NCT00561275 2008-07-15
Safety Study of Multiple Peptide Vaccine to Esophageal Cancer
Japanese Foundation for Cancer Research
Phase 1 Completed